Blood test guides next steps in aggressive lung cancer fight
NCT ID NCT07357532
Summary
This study is for people with a specific type of lung cancer (limited-stage small cell) who have finished their initial chemo-radiation treatment. Researchers will use a special blood test to look for tiny traces of leftover cancer. If the test is positive, patients will receive a combination of immunotherapy and a drug that blocks blood vessel growth, with the goal of clearing the cancer and preventing it from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital & Institute
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.